Free Trial

Corvus Pharmaceuticals (CRVS) SEC Filings & 10K Form

Corvus Pharmaceuticals logo
$4.70 -2.69 (-36.40%)
(As of 09:46 AM ET)

Recent Corvus Pharmaceuticals SEC Filings

DateFilerForm TypeView
10/23/2024
3:11 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
11:15 PM
Corvus Pharmaceuticals (Filer)
Form EFFECT
08/06/2024
4:31 PM
Corvus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/01/2024
8:18 PM
Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
Form SC 13G/A
06/17/2024
5:46 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:48 PM
CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:41 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:43 PM
Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:44 PM
Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:29 PM
Corvus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
05/08/2024
7:28 PM
Corvus Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
7:34 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:55 PM
Corvus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
05/07/2024
4:16 PM
Corvus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
4:19 PM
Corvus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/03/2024
3:05 PM
Corvus Pharmaceuticals (Filer)
Form 424B5
05/01/2024
4:06 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
4:57 PM
Arcara Jeffrey (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
12:31 PM
Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
Form SC 13G
02/13/2024
5:27 PM
Corvus Pharmaceuticals (Subject)
MILLER RICHARD A MD (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRVS) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners